Date:09/09/2008 URL: http://www.thehindu.com/2008/09/09/stories/2008090956431500.htm

Business - Briefly

Aurobindo Pharma gets FDA nod for ARV drugs

HYDERABAD: Aurobindo Pharma had received tentative approval to manufacture and market Abacavir Sulfate/Lamivudine tablets 600 mg/300 mg from the US-FDA. These tablets are generic equivalents of Epzicom of SmithKline Beecham and fall under anti-retroviral segment, according to a release. — Special Correspondent